Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-10-01
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishment of a Patient Library in Patients With Pruritus Sine Materia
NCT05678309
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
NCT00697034
Neurobiology of the Scalp in Seborrheic Dermatitis
NCT02349854
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT03272958
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 1 skin biopsy of the scalp (non-routine medical procedure)
* Completion of questionnaires
40 adult women
* 20 women with a sensitive scalp (cases)
* 20 women without a sensitive scalp (controls)
Patientes with the sensitive scalp will be recruited from the dermatology department. There will be no further visits, so the duration of the study is 1 day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group (patient with sensitive scalp)
A 'sensitive scalp' group, with an overall 3S score ≥3 and a pruritus sub-score ≥2. As pruritus is widely described as the main symptom of sensitive scalp, recruitment will be based on the presence of pruritus.
A scalp biopsy using a 4 mm punch in the retroauricular hair zone
a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia
a general health questionnaire
a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.
Questionnaires concerning their sensitive scalp
* The characteristics of a sensitive scalp (location, chronicity, triggering and soothing factors, use of cosmetics, etc.)
* Sensitive Scalp Score (3S)
* Impact on quality of life: BoSS questionnaire
* Impact of pruritus on quality of life (ItchyQol)
Control group (patient with "normal" scalp)
\- A 'non-sensitive scalp' group, with a 3S score of 0.
A scalp biopsy using a 4 mm punch in the retroauricular hair zone
a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia
a general health questionnaire
a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A scalp biopsy using a 4 mm punch in the retroauricular hair zone
a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia
a general health questionnaire
a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.
Questionnaires concerning their sensitive scalp
* The characteristics of a sensitive scalp (location, chronicity, triggering and soothing factors, use of cosmetics, etc.)
* Sensitive Scalp Score (3S)
* Impact on quality of life: BoSS questionnaire
* Impact of pruritus on quality of life (ItchyQol)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Collection of free and informed consent
* patient affiliated to a social security scheme
For the control group: Sensiscalp score = 0/20 Sensitive scalp group: Sensiscalp score ≥ 3/20 with pruritus sensation ≥ 2/20
Exclusion Criteria
* Dermatosis of the scalp (psoriasis, seborrhoeic dermatitis, etc.)
* Pregnant and breast-feeding women
* Women under legal protection (guardianship, curatorship)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC24.0318 - SENSISCALP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.